ondansetron has been researched along with Fungemia in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Fungemia: The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orsini, M | 1 |
| Otaíza, F | 1 |
| Vega, P | 1 |
| Hederra, LM | 1 |
| Pidal, P | 1 |
| Salas, V | 1 |
| Coria, P | 1 |
| Urízar, C | 1 |
| Sepúlveda, D | 1 |
| Palma, M | 1 |
| Fernández, J | 1 |
| Martínez, MC | 1 |
| Hormazábal, JC | 1 |
1 other study available for ondansetron and Fungemia
| Article | Year |
|---|---|
[Outbreak of fungemias by Sarocladium kiliense in eight public hospitals per intrinsic contamination of ondansetron intravenous].
Topics: Adolescent; Child; Child, Preschool; Chile; Cross Infection; Disease Outbreaks; Drug Contamination; | 2018 |